Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome.
Ye WeiChong LiHuifang BianWei QianKairui JinTingting XuXiaomao GuoXueguan LuFengtao SuPublished in: Molecular cancer (2021)
Our work indicates the CDK7-dependent transcription addiction of inflammatory genes. Targeting CDK7 is a promising strategy for treating CRS by inhibiting multiple cytokines.